C1q nephropathy in the pediatric population: Pathology and pathogenesis

Pediatric Nephrology

Volumn 25, Issue 8, 2010, Pages 1385-1396

  Wenderfer, Scott E ^a   Swinford, Rita D ^a   Braun, Michael C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

C1q; C1q nephropathy; Complement; Focal segmental glomerular sclerosis; Mesangial proliferation; Nephrotic syndrome

Indexed keywords

COMPLEMENT COMPONENT C1Q;

C1Q NEPHROPATHY; CHILD; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; BIOPSY; CHRONIC DISEASE; GLOMERULONEPHRITIS; PATHOLOGY; POPULATION GROUP;

BIOPSY; CHILD; CHRONIC DISEASE; GLOMERULONEPHRITIS; HUMANS; KIDNEY DISEASES; POPULATION GROUPS;

EID: 77954424035     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1429-x     Document Type: Review

References (72)

1. DK Peters DG Williams 1972 Complement and the kidney Proc R Soc Med 65 1095 1098 1:CAS:528:DyaE3sXislCmtQ%3D%3D 4568538
2. Neilson EG, Couser WG (2001) Immunologic renal diseases. Lippincott Williams & Wilkins, Nashville, p 1311
3. D Turnberg HT Cook 2005 Complement and glomerulonephritis: new insights Curr Opin Nephrol Hypertens 14 223 228 10.1097/01.mnh.0000165887.75501.24 1:CAS:528:DC%2BD2MXltVKrurY%3D 15821414
4. RJ Quigg 2003 Complement and the kidney J Immunol 171 3319 3324 1:CAS:528:DC%2BD3sXnvFSrsb4%3D 14500622
5. MA Seelen MR Daha 2006 The role of complement in autoimmune renal disease Autoimmunity 39 411 415 10.1080/08916930600739688 1:CAS:528:DC%2BD28XhtFamtLvF 16923541 (Pubitemid 44269619)
6. Fogo AB, Kashgarian M (2005) Diagnostic atlas of renal pathology. Saunders, Philadelphia, p 480
7. Jennette JC, Olson JL, Schwartz MM, Silva FG (2006) Heptinstall's pathology of the kidney. Lippincott Williams & Wilkins, Baltimore
8. RJ Smith J Alexander PN Barlow M Botto TL Cassavant HT Cook SR de Cordoba GS Hageman TS Jokiranta WJ Kimberling JD Lambris LD Lanning V Levidiotis C Licht HU Lutz S Meri MC Pickering RJ Quigg AL Rops DJ Salant S Sethi JM Thurman HF Tully SP Tully J van der Vlag PD Walker R Würzner PF Zipfel Dense Deposit Disease Focus Group 2007 New approaches to the treatment of dense deposit disease J Am Soc Nephrol 18 2447 2456 10.1681/ASN.2007030356 1:CAS:528:DC%2BD2sXhtV2mur3L 17675665 (Pubitemid 47378860)
9. A Servais V Fremeaux-Bacchi M Lequintrec R Salomon J Blouin B Knebelmann JP Grunfeld P Lesavre LH Noel F Fakhouri 2007 Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with hemolytic uremic syndrome J Med Genet 44 193 199 10.1136/jmg.2006.045328 1:CAS:528:DC%2BD2sXkvFehtLc%3D 17018561 (Pubitemid 46580528)
10. S Habbig MJ Mihatsch S Heinen B Beck M Emmel C Skerka M Kirschfink B Hoppe PF Zipfel C Licht 2009 C3 deposition glomerulopathy due to a functional factor H defect Kidney Int 75 1230 1234 10.1038/ki.2008.354 18633337
11. A Mii A Shimizu Y Masuda E Fujita K Aki M Ishizaki S Sato A Griesemer Y Fukuda 2009 Current status and issues of C1q nephropathy Clin Exp Nephrol 13 263 274 10.1007/s10157-009-0159-5 1:CAS:528:DC%2BD1MXhtF2isbvE 19373520
12. A Vizjak D Ferluga M Rozic A Hvala J Lindic TK Levart V Jurcic JC Jennette 2008 Pathology, clinical presentations, and outcomes of C1q nephropathy J Am Soc Nephrol 19 2237 2244 10.1681/ASN.2007080929 18650484
13. GJ Arlaud C Gaboriaud NM Thielens V Rossi 2002 Structural biology of C1 Biochem Soc Trans 30 1001 1006 10.1042/BST0301001 1:CAS:528:DC%2BD38XovF2isLg%3D 12440961 (Pubitemid 36002395)
14. F Petry G Hauptmann J Goetz E Grosshans M Loos 1997 Molecular basis of a new type of C1q-deficiency associated with a non-functional low molecular weight (LMW) C1q: parallels and differences to other known genetic C1q-defects Immunopharmacology 38 189 201 10.1016/S0162-3109(97)00065-9 1:CAS:528: DyaK2sXotVyksLg%3D 9476130 (Pubitemid 28049979)
15. Loos M, Martin H, Petry F (1989) The biosynthesis of C1q, the collagen-like and Fc recognizing molecule of the complement system. Behring Inst Mitt (84):32-41
16. R Hoekzema AJ Swaak MC Brouwer A van Rooijen EJ Nieuwenhuys CE Hack 1990 Significance of low molecular weight C1q in systemic lupus erythematosus Ann Rheum Dis 49 698 704 10.1136/ard.49.9.698 1:STN:280:DyaK3M%2FltlegtA%3D%3D 2241286
17. W Muller H Hanauske-Abel M Loos 1978 Biosynthesis of the first component of complement by human and guinea pig peritoneal macrophages: evidence for an independent production of the C1 subunits J Immunol 121 1578 1584 1:STN:280:DyaE1M%2FivValuw%3D%3D 701808
18. JH Lu BK Teh L Wang YN Wang YS Tan MC Lai KB Reid 2008 The classical and regulatory functions of C1q in immunity and autoimmunity Cell Mol Immunol 5 9 21 10.1038/cmi.2008.2 1:CAS:528:DC%2BD1cXksFKisLY%3D 18318990
19. RJ Ziccardi J Tschopp 1982 The dissociation properties of native C1 Biochem Biophys Res Commun 107 618 623 10.1016/0006-291X(82)91536-4 1:CAS:528:DyaL38XkvFShsL4%3D 6289835
20. CL Villiers GJ Arlaud RH Painter MG Colomb 1980 Calcium binding properties of the C1 subcomponents C1q, C1r and C1s FEBS Lett 117 289 294 10.1016/0014-5793(80)80964-1 1:CAS:528:DyaL3cXls1Grtb8%3D 6250896 (Pubitemid 11246515)
21. W Augener HM Grey NR Cooper HJ Muller-Eberhard 1971 The reaction of monomeric and aggregated immunoglobulins with C1 Immunochemistry 8 1011 1020 10.1016/0019-2791(71)90489-7 1:CAS:528:DyaE38XitlOkug%3D%3D 4945437
22. AR Duncan G Winter 1988 The binding site for C1q on IgG Nature 332 738 740 10.1038/332738a0 1:CAS:528:DyaL1cXkt1Wgt78%3D 3258649
23. RJ Ziccardi 1983 The first component of human complement (C1): activation and control Springer Semin Immunopathol 6 213 230 10.1007/BF00205874 1:CAS:528:DyaL2cXksVer 6314572
24. D Mevorach JO Mascarenhas D Gershov KB Elkon 1998 Complement-dependent clearance of apoptotic cells by human macrophages J Exp Med 188 2313 2320 10.1084/jem.188.12.2313 1:CAS:528:DyaK1MXhtFejsg%3D%3D 9858517 (Pubitemid 29028503)
25. ME van den Dobbelsteen FJ van der Woude WE Schroeijers N Klar-Mohamad LA van Es MR Daha 1993 C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells J Immunol 151 4315 4324 8409404
26. T Sato MG van Dixhoorn E Heemskerk LA van Es MR Daha 1997 C1q, a subunit of the first component of complement, enhances antibody-mediated apoptosis of cultured rat glomerular mesangial cells Clin Exp Immunol 109 510 517 10.1046/j.1365-2249.1997.4741372.x 1:CAS:528:DyaK2sXmt1Oru7w%3D 9328130
27. J Cortes-Hernandez L Fossati-Jimack A Carugati PK Potter MJ Walport HT Cook M Botto 2002 Murine glomerular mesangial cell uptake of apoptotic cells is inefficient and involves serum-mediated but complement-independent mechanisms Clin Exp Immunol 130 459 466 10.1046/j.1365-2249.2002.01998.x 1:CAS:528:DC%2BD3sXjvFOrug%3D%3D 12452836 (Pubitemid 35418329)
28. ME van den Dobbelsteen FJ van der Woude WE Schroeijers N Klar-Mohamad LA van Es MR Daha 1996 Both IgG-and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells J Am Soc Nephrol 7 573 581 8724891
29. M Trendelenburg 2005 Antibodies against C1q in patients with systemic lupus erythematosus Springer Semin Immunopathol 27 276 285 10.1007/s00281-005- 0007-y 1:CAS:528:DC%2BD2MXht1SqtLfK 16189648 (Pubitemid 41639881)
30. R Ghai P Waters LT Roumenina M Gadjeva MS Kojouharova KB Reid RB Sim U Kishore 2007 C1q and its growing family Immunobiology 212 253 266 10.1016/j.imbio.2006.11.001 1:CAS:528:DC%2BD2sXnvFCmtb8%3D 17544811 (Pubitemid 46830353)
31. JC Jennette CG Hipp 1985 Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens Am J Clin Pathol 83 415 420 1:STN:280: DyaL2M7ntFyitQ%3D%3D 3885712
32. JC Jennette CG Hipp 1985 C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome Am J Kidney Dis 6 103 110 1:STN:280:DyaL2M3ns1altw%3D%3D 3875286
33. SS Iskandar MC Browning WB Lorentz 1991 C1q nephropathy: a pediatric clinicopathologic study Am J Kidney Dis 18 459 465 1:STN:280: DyaK38%2Fis1Smsw%3D%3D 1928065
34. KK Lau LW Gaber NM Delos Santos RJ Wyatt 2005 C1q nephropathy: features at presentation and outcome Pediatr Nephrol 20 744 749 10.1007/s00467-004-1810-8 15827744 (Pubitemid 40663156)
35. T Kersnik Levart RB Kenda M Avgustin Cavic D Ferluga A Hvala A Vizjak 2005 C1Q nephropathy in children Pediatr Nephrol 20 1756 1761 10.1007/s00467-005-2040-4 16247648 (Pubitemid 41722960)
36. Y Fukuma S Hisano Y Segawa K Niimi N Tsuru Y Kaku K Hatae Y Kiyoshi A Mitsudome H Iwasaki 2006 Clinicopathologic correlation of C1q nephropathy in children Am J Kidney Dis 47 412 418 10.1053/j.ajkd.2005.11.013 16490619 (Pubitemid 43255174)
37. CS Wong CA Fink J Baechle AA Harris AO Staples JR Brandt 2009 C1q nephropathy and minimal change nephrotic syndrome Pediatr Nephrol 24 761 767 10.1007/s00467-008-1058-9 19082635
38. I Roberti N Baqi S Vyas DU Kim 2009 A single-center study of C1q nephropathy in children Pediatr Nephrol 24 77 82 10.1007/s00467-008-0939-2 18688655
39. M Nishida H Kawakatsu Y Okumura K Hamaoka 2005 C1q nephropathy with asymptomatic urine abnormalities Pediatr Nephrol 20 1669 1670 10.1007/s00467-005-2024-4 16133042 (Pubitemid 41554489)
40. M Kuwano Y Ito Y Amamoto K Aida 1993 A case of congenital nephrotic syndrome associated with positive C1q immunofluorescence Pediatr Nephrol 7 452 454 10.1007/BF00857571 1:STN:280:DyaK2c%2FgtFChsQ%3D%3D 8398660
41. SB Shappell G Myrthil A Fogo 1997 An adolescent with relapsing nephrotic syndrome: minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy Am J Kidney Dis 29 966 970 10.1016/S0272-6386(97)90475-3 1:STN:280:DyaK2szivFKisA%3D%3D 9186086
42. M Nishida H Kawakatsu H Komatsu K Ishiwari M Tamai T Sawada 2000 Spontaneous improvement in a case of C1q nephropathy Am J Kidney Dis 35 E22 10.1016/S0272-6386(00)70287-3 1:STN:280:DC%2BD3c3lsFGlug%3D%3D 10793051
43. T Srivastava V Chadha EM Taboada US Alon 2000 C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis Pediatr Nephrol 14 976 979 10.1007/s004670050056 1:STN:280:DC%2BD3M%2FltVGhtQ%3D%3D 10975310
44. M Ekim A Ikinciogullari M Berberoglu O Tulunay H Sencer N Ozkaya I Reisli N Tumer 2002 C1q nephropathy: a case with severe atopic dermatitis Pediatr Nephrol 17 547 549 10.1007/s00467-002-0904-4 12172773 (Pubitemid 36097323)
45. I Roberti S Sachdev A Aronsky DU Kim 2006 C1q nephropathy in a child with a chromosome 13 deletion Pediatr Nephrol 21 737 739 10.1007/s00467-006-0046-1 16520946
46. CS Krinsky A Harris 2006 An 18-year-old woman with proteinuria and renal insufficiency. C1q nephropathy Arch Pathol Lab Med 130 e53 e55 16594760
47. C Hanevold A Mian R Dalton 2006 C1q nephropathy in association with Gitelman syndrome: a case report Pediatr Nephrol 21 1904 1908 10.1007/s00467-006-0261-9 16955279 (Pubitemid 44741172)
48. IS Lim KW Yun KC Moon HI Cheong 2007 Proteinuria in a boy with infectious mononucleosis, C1q nephropathy, and Dent's disease J Korean Med Sci 22 928 931 10.3346/jkms.2007.22.5.928 17982249
49. JA Kari SM Jalalah 2008 C1q nephropathy in two young sisters Pediatr Nephrol 23 487 490 10.1007/s00467-007-0644-6 17952693 (Pubitemid 351168117)
50. M Bitzan JD Ouahed P Krishnamoorthy C Bernard 2008 Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution Pediatr Nephrol 23 1355 1361 10.1007/s00467-008-0781-6 18351394
51. L Taggart A Harris S El-Dahr F Iorember 2010 C1q nephropathy in a child presenting with recurrent gross hematuria Pediatr Nephrol 25 165 168 10.1007/s00467-009-1290-y
52. Jennette JC (2004) C1q nephropathy. In: Massry SG, Glassock RJ (eds) Textbook of nephrology. Lippincott, Williams & Wilkins, Philadelphia, pp 730-733
53. A Davenport AG Maciver JC Mackenzie 1992 C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome? Nephrol Dial Transplant 7 391 396 1:STN:280:DyaK38zjsVOisw%3D%3D 1321373
54. International Study of Kidney Diseases in Children 1978 Nephrotic syndrome in children: prediction of histology from clinical and laboratory characteristics at the time of diagnosis Kidney Int 13 159 165 10.1038/ki.1978.23
55. P Tarshish JN Tobin J Bernstein CM Edelmann Jr 1997 Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children J Am Soc Nephrol 8 769 776 1:STN:280:DyaK2szhvF2lsg%3D%3D 9176846
56. EM Hodson JC Craig NS Willis 2005 Evidence-based management of steroid-sensitive nephrotic syndrome Pediatr Nephrol 20 1523 1530 10.1007/s00467-005-1968-8 15968558 (Pubitemid 41554459)
57. Hodson EM, Knight JF, Willis NS, Craig JC (2005) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev (1):CD001533
58. JL Colquitt J Kirby C Green K Cooper RS Trompeter 2007 The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review Health Technol Assess 11 1 93
59. WR Allen LB Travis T Cavallo BH Brouhard RJ Cunningham 3rd 1982 Immune deposits and mesangial hypercellularity in minimal change nephrotic syndrome: clinical relevance J Pediatr 100 188 191 10.1016/S0022-3476(82)80632-X 1:STN:280:DyaL387it1Shsw%3D%3D 7057326
60. [no authors listed] 1983 Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. A report of the Southwest Pediatric Nephrology Study Group Kidney Int 24 87 94 10.1038/ki.1983.129
61. DM Silverstein RD Craver 2008 Mesangial hypercellularity in children: presenting features and outcomes Pediatr Nephrol 23 921 928 10.1007/s00467-008- 0750-0 18324424
62. HW Schnaper 2003 Idiopathic focal segmental glomerulosclerosis Semin Nephrol 23 183 193 10.1053/snep.2003.50016 12704578 (Pubitemid 36397100)
63. DS Gipson K Gibson PE Gipson S Watkins M Moxey-Mims 2007 Therapeutic approach to FSGS in children Pediatr Nephrol 22 28 36 10.1007/s00467-006-0310-4 17109140 (Pubitemid 46138357)
64. Hodson EM, Habashy D, Craig JC (2006) Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Syst Rev (2):CD003594
65. M Wehrmann A Bohle H Held G Schumm H Kendziorra H Pressler 1990 Longterm prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes Clin Nephrol 33 115 122 1:STN:280:DyaK3c3htl2ksw%3D%3D 2323110
66. KH Paik BH Lee HY Cho HG Kang IS Ha HI Cheong DK Jin KC Moon Y Choi 2007 Primary focal segmental glomerular sclerosis in children: clinical course and prognosis Pediatr Nephrol 22 389 395 10.1007/s00467-006-0301-5 17058050 (Pubitemid 46766764)
67. AS Abeyagunawardena NJ Sebire RA Risdon MJ Dillon L Rees W Van't Hoff PV Kumarasiri RS Trompeter 2007 Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis Pediatr Nephrol 22 215 221 10.1007/s00467-006-0264-6 17146670 (Pubitemid 44964322)
68. A Rifai M Mannik 1983 Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA J Immunol 130 1826 1832 1:CAS:528:DyaL3sXhslOgsr8%3D 6833754
69. A Rifai K Millard 1985 Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA Clin Exp Immunol 60 363 368 1:STN:280:DyaL2M3ivFSjsQ%3D%3D 3891168 (Pubitemid 15099885)
70. SN Emancipator 1988 Experimental models of IgA nephropathy Am J Kidney Dis 12 415 419 1:STN:280:DyaL1M%2FkslChsA%3D%3D 3055967
71. C Gomez-Guerrero MJ Lopez-Armada E Gonzalez J Egido 1994 Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation J Immunol 153 5247 5255 1:CAS:528:DyaK2MXit1GjsbY%3D 7963578 (Pubitemid 24983927)
72. TK Chao A Rifai SM Ka SM Yang HA Shui YF Lin HK Sytwu WH Lee JT Kung A Chen 2006 The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy Kidney Int 70 283 297 10.1038/sj.ki.5001533 1:CAS:528:DC%2BD28XmvFags7o%3D 16738538 (Pubitemid 44086578)